◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › E › ERIS

Eris Lifesciences Limited (ERIS) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-11-02

Eris Lifesciences Limited (ERIS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Ahmedabad, India with about 2,758 employees. Its market capitalization is roughly ₹161 billion. In the fiscal year ended 2026-03-31, ERIS reported ₹31.1B in revenue and ₹6.2B in net income.

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.

Interactive charts & full statements → Open the ERIS valuation workbench →

ERIS Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-09-302026-03-312025-03-312024-03-312023-03-312022-03-31
Total Revenue₹33.1B₹31.1B₹28.8B₹19.9B₹16.6B—
Gross Profit₹24.4B₹23.0B₹21.5B₹16.0B₹13.0B—
Operating Income (EBIT)₹8.8B₹8.4B₹7.0B₹5.0B₹4.2B—
Net Income₹7.1B₹6.2B₹3.5B₹3.9B₹3.8B—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ERIS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-09-302026-06-302026-03-312025-12-312025-09-30
Total Revenue₹8.9B₹8.7B₹7.5B₹8.0B₹7.9B
Gross Profit₹6.6B₹6.3B₹5.7B₹5.8B₹5.9B
Operating Income (EBIT)₹2.4B₹2.2B₹2.0B₹2.1B₹2.2B
Net Income₹1.8B₹1.4B₹2.8B₹997M₹1.2B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ERIS Free Cash Flow History

Cash flow2026-03-312025-03-312024-03-312023-03-312022-03-31
Dividends Paid—(₹1.0B)—(₹999M)(₹816M)

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ERIS Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-312022-03-31
Total Assets₹73.7B₹70.4B₹70.4B₹36.7B—
Total Liabilities₹34.7B₹37.6B₹38.2B₹14.5B—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ERIS viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← ERIIAll “E” companiesERKA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.